Efficacy and Safety Measurements of Proton Pump Inhibitors in Infants and Children

Author:

James Laura P.12

Affiliation:

1. Associate Professor, Section of Clinical Pharmacology and Toxicology Department of Pediatrics University of Arkansas for Medical Sciences and Arkansas Children's Hospital Arkansas U.S.A.

2. Co‐Principal Investigator, Pediatric Pharmacology Research Unit Little Rock Arkansas U.S.A.

Abstract

ABSTRACTThe design of studies to evaluate the efficacy of acid‐lowering drugs in children differs significantly from study designs in adult populations. Efficacy measurements may be less extensive than those used in adult studies because of limitations that exist secondary to concerns for patient safety, parental and institutional review board acceptance of efficacy end points, and existing standards of care within the pediatric gastroenterology community. Study designs involving patients who would routinely receive acid‐lowering therapy have been successfully used to characterize the pharmacokinetics and pharmacodynamics of acid‐lowering therapies (H2 receptor antagonists) and have led to pediatric labeling for these drugs. This approach may likewise be used in the study of newer acid‐lowering agents, such as proton pump inhibitors.

Funder

National Institute of Child Health and Human Development

Publisher

Wiley

Reference12 articles.

1. Clinical Trials in Children

2. Indications for Pediatric Gastrointestinal Endoscopy: A Medical Position Statement of the North American Society for Pediatric Gastroenterology and Nutrition

3. Statement of the North American Society for Pediatric Gastroenterology and Nutrition (NASPGN) Indications for Pediatric Esophageal pH Monitoring

4. SubpartD.Title 45 Code of Federal Regulations Part 46 (45 CFR 46).

5. Committee on Drugs, American Academy of Pediatrics;Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations.;Pediatrics,1995

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3